A Phase 3, randomized, double-blind, study evaluating efficacy and safety of riliprubart versus intravenous immunoglobulin (IVIg) in participants with chronic inflammatory demyelinating polyneuropathy (VITALIZE)

GO TO STUDY

Non-Invasive Testing of blood biomarkers in pregnAnt women (NITA)

GO TO STUDY

Oxford Musculoskeletal Biobank RENEWAL

GO TO STUDY

Natural History studies of participants with primary and secondary headache and facial pain disorders

GO TO STUDY

Human brain mechanisms underlying motivation and apathy

GO TO STUDY

Investigating the effects of beta transcranial stimulation to advance stroke rehabilitation (T-STAR)

GO TO STUDY

Oxford Luteal Dysfunction and Placental Insufficiency Study (OxLuPIn)

GO TO STUDY

INTEGRATOR Research Tissue Bank

GO TO STUDY

Cancer and neoplasms

A prospective randomized, double-blind, placebo-controlled, multi-center phase IIb study to evaluate the efficacy and safety of mocravimod in acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplant (HSCT) (MO-TRANS (PKRPCOO1))

GO TO STUDY

PREDICT – Psoriatic arthritis Recognising Early Disease Indicators Conferring Treatment response. A pilot study to identify biomarkers to predict biologic response in patients with Psoriatic Arthritis commencing a second or third biologic drug

GO TO STUDY